Literature DB >> 11278647

Tumor suppressor p53 protein is a new target for the metastasis-associated Mts1/S100A4 protein: functional consequences of their interaction.

M Grigorian1, S Andresen, E Tulchinsky, M Kriajevska, C Carlberg, C Kruse, M Cohn, N Ambartsumian, A Christensen, G Selivanova, E Lukanidin.   

Abstract

A physical and functional interaction between the Ca(2+)-binding protein Mts1 (S100A4) and the tumor suppressor p53 protein is shown here for the first time. We demonstrate that Mts1 binds to the extreme end of the C-terminal regulatory domain of p53 by several in vitro and in vivo approaches: co-immunoprecipitation, affinity chromatography, and far Western blot analysis. The Mts1 protein in vitro inhibits phosphorylation of the full-length p53 and its C-terminal peptide by protein kinase C but not by casein kinase II. The Mts1 binding to p53 interferes with the DNA binding activity of p53 in vitro and reporter gene transactivation in vivo, and this has a regulatory function. A differential modulation of the p53 target gene (p21/WAF, bax, thrombospondin-1, and mdm-2) transcription was observed upon Mts1 induction in tet-inducible cell lines expressing wild type p53. Mts1 cooperates with wild type p53 in apoptosis induction. Our data imply that the ability of Mts1 to enhance p53-dependent apoptosis might accelerate the loss of wild type p53 function in tumors. In this way, Mts1 can contribute to the development of a more aggressive phenotype during tumor progression.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11278647     DOI: 10.1074/jbc.M010231200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  93 in total

1.  Protein S100A4: too long overlooked by pathologists?

Authors:  Luca Mazzucchelli
Journal:  Am J Pathol       Date:  2002-01       Impact factor: 4.307

Review 2.  Epithelial-mesenchymal transitions and the intersecting cell fate of fibroblasts and metastatic cancer cells.

Authors:  Eric G Neilson; David Plieth; Christo Venkov
Journal:  Trans Am Clin Climatol Assoc       Date:  2003

Review 3.  S100 proteins in cartilage: role in arthritis.

Authors:  Raghunatha R Yammani
Journal:  Biochim Biophys Acta       Date:  2012-01-12

4.  Crystal structure of the S100A4-nonmuscle myosin IIA tail fragment complex reveals an asymmetric target binding mechanism.

Authors:  Bence Kiss; Annette Duelli; László Radnai; Katalin A Kékesi; Gergely Katona; László Nyitray
Journal:  Proc Natl Acad Sci U S A       Date:  2012-03-28       Impact factor: 11.205

5.  TD-11 workshop report: characterization of monoclonal antibodies to S100 proteins.

Authors:  Elisabeth Paus; Mads Haugland Haugen; Kari Hauge Olsen; Kjersti Flatmark; Gunhild Mari Maelandsmo; Olle Nilsson; Eva Röijer; Maria Lundin; Christian Fermér; Maria Samsonova; Yuri Lebedin; Torgny Stigbrand
Journal:  Tumour Biol       Date:  2010-07-24

6.  Circulating S100 proteins effectively discriminate SLE patients from healthy controls: a cross-sectional study.

Authors:  Barbora Šumová; Lucie Andrés Cerezo; Lenka Szczuková; Lucie Nekvindová; Michal Uher; Hana Hulejová; Radka Moravcová; Mariam Grigorian; Karel Pavelka; Jiří Vencovský; Ladislav Šenolt; Jakub Závada
Journal:  Rheumatol Int       Date:  2018-11-03       Impact factor: 2.631

7.  Proteins of the S100 family regulate the oligomerization of p53 tumor suppressor.

Authors:  Maria Rosario Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  Proc Natl Acad Sci U S A       Date:  2005-03-21       Impact factor: 11.205

8.  Members of the S100 family bind p53 in two distinct ways.

Authors:  Maria Rosario Fernandez-Fernandez; Trevor J Rutherford; Alan R Fersht
Journal:  Protein Sci       Date:  2008-08-11       Impact factor: 6.725

9.  Modulation of the oligomerization state of p53 by differential binding of proteins of the S100 family to p53 monomers and tetramers.

Authors:  Jan van Dieck; Maria R Fernandez-Fernandez; Dmitry B Veprintsev; Alan R Fersht
Journal:  J Biol Chem       Date:  2009-03-18       Impact factor: 5.157

10.  Hepatocyte growth factor/scatter factor mediates angiogenesis through positive VEGF and negative thrombospondin 1 regulation.

Authors:  Yu-Wen Zhang; Yanli Su; Olga V Volpert; George F Vande Woude
Journal:  Proc Natl Acad Sci U S A       Date:  2003-10-10       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.